Widely used cholesterol-lowering statin drugs like Lipitor (atorvastatin), Crestor (rosuvastatin), Zocor (simvastatin), Simcor (simvastatin/niacin extended-release), Vytorin (simvastatin/ezetimibe) and many others will now have additional warnings on their packaging, according to an announcement from the Food & Drug Administration. [More]
simcor
![Zocor Can Increase Chance Of Muscle Injury & Kidney Damage: FDA](../../consumermediallc.files.wordpress.com/2012/06/zocor-sign.jpg?w=240&h=180&crop=1)
Zocor Can Increase Chance Of Muscle Injury & Kidney Damage: FDA
While myopathy (muscle injury) is a known side effect for all cholesterol-lowering statin medications, the FDA has just issued a warning that, when prescribed and used at higher doses, Zocor (generic name: simvastatin) carries with it a greater risk of developing muscle injury, including the most serious form of myopathy, rhabdomyolysis, which can lead to kidney damage, kidney failure, and possibly death. [More]